deltatrials
Completed PHASE1/PHASE2 INTERVENTIONAL 1-arm NCT01108042

TPF-Induction Chemotherapy of Oropharyngeal and Cavity of the Mouth Cancer

Phase I/II Study of Split-dose TPF-Induction Chemotherapy Before Surgery of Oropharyngeal and Cavity of the Mouth Cancer

Sponsor: Orlando Guntinas-Lichius, Prof. Dr. med.

Conditions Oropharynx Cancer Squamous Cell Carcinoma of the Oral Cavity
Interventions Taxotere, Cisplatin, 5-Fluorouracil (5-FU)
Updated 5 times since 2017 Last updated: May 17, 2016 Started: Nov 30, 2009 Primary completion: Jan 31, 2016 Completion: Feb 29, 2016
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1/PHASE2 clinical study on Oropharynx Cancer and Squamous Cell Carcinoma of the Oral Cavity, this trial is completed. The trial is conducted by Orlando Guntinas-Lichius, Prof. Dr. med. and has accumulated 5 data snapshots since 2009. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 21 months · monthly snapshotCompleted

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE1/PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1/PHASE2

    Phase: PHASE1_PHASE2 → PHASE1/PHASE2

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE1_PHASE2

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE1_PHASE2

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE1_PHASE2

    First recorded

Nov 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Orlando Guntinas-Lichius, Prof. Dr. med.
Data source: University of Jena

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations